Polysaccharides as therapeutic vehicles in pancreatic cancer.
1/5 보강
Pancreatic cancer (PC) is highly aggressive, with rising incidence and mortality rates.
APA
Kumari S, Peela S, et al. (2025). Polysaccharides as therapeutic vehicles in pancreatic cancer.. Drug discovery today, 30(3), 104320. https://doi.org/10.1016/j.drudis.2025.104320
MLA
Kumari S, et al.. "Polysaccharides as therapeutic vehicles in pancreatic cancer.." Drug discovery today, vol. 30, no. 3, 2025, pp. 104320.
PMID
40024518 ↗
Abstract 한글 요약
Pancreatic cancer (PC) is highly aggressive, with rising incidence and mortality rates. It has significant therapy obstacles due to the limited clinical options, late-stage identification, dense tumor microenvironment (TME), and resistance to therapy. Recent advances might improve treatment consequences in therapy strategies that target important TME components. Moreover, new polymeric drug delivery techniques based on polysaccharides such as polymeric micelles, liposomes, and nanoparticles enhance the solubility of drugs, drug stability, and tumor-specific targeting, which increase the chances of circumventing resistance and improving the efficacy of treatment. Preclinical research has suggested that by modulating the TME and enhancing the efficacy of chemotherapy, polysaccharide-based therapy, such as RP02-1 and DPLL-functionalized amylose, may help treat PC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Quality of Life Measurement in PARP Inhibitor Trials of Epithelial Ovarian Cancer - What Do We Know?
- Artificial intelligence in gynecologic oncology: A cautionary look in the Indian context.
- Foodborne Mycotoxins as Molecular and Epigenetic Carcinogens: Biochemical Mechanisms and Toxicological Implications.
- The RNA-binding protein Quaking is essential for cardiac homeostasis and function by regulating Morf4l2 splicing.
- Briefing on Nitric Oxide a Signal Molecule in Cancer Metastasis and Therapeutic Target.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.